Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Five-Year Experience with Transcystic Laparoscopic Common Bile Duct Exploration
Wahi, Jessica E. , Warmack, Tyler, Barghout, Robert, Kashif, Kareem, Rosario, Luis E., Davies, Jennifer, Unger, S. W., Joshi, Devendra, Jorge, Irving , Unger, Stephen W.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | December 2, 2022 | Volume: 33 | Issue: 3 | Pages: 276-280

10.1089/lap.2022.0408 | PMID 36459625 Get It

Background: Common bile duct (CBD) stones associated with cholecystitis can be treated by single-stage CBD exploration at the time of cholecystectomy or a two-stage approach with endoscopic stone extraction before or after cholecystectomy. The ideal management remains a matter of debate. The aim of this study is to analyze our outcomes with transcystic laparoscopic common bile duct exploration (LCBDE). Material and Methods: A retrospective review of patients who underwent transcystic LCBDE between 2015 and 2019 was performed. Results: A total of 106 patients underwent transcystic LCBDE over 5 years. We performed 1192 laparoscopic cholecystectomies with cholangiograms from March 2015 to December 2019. Fifteen patients had a preoperative endoscopic retrograde cholangiopancreatography (ERCP) for CBD stones seen on magnetic resonance cholangiopancreatography that during laparoscopic cholecystectomy with intraoperative cholangiogram (IOC), there were stones and/or sludge found in the CBD, which required clearance through a transcystic approach. Of the 91 patients who did not have a preoperative ERCP, clearance of the CBD was successful through a transcystic approach in 78 patients (86%). In the 13 patients that intraoperative clearance was not achieved ( n = 13, 14%), a postoperative ERCP was performed. A total of 28 patients underwent either pre- or postoperative ERCP ( n = 28, 26%). Choledochotomy was not performed in any of the patients. The mean operative time was 127 minutes (127 ± 48). The mean hospital length of stay (LOS) was 4 days (3.9 ± 2.8) with a median LOS of 3 days. Complications observed include wound infection ( n = 2, 2%), pancreatitis after ERCP ( n = 1, 1%), pneumonia ( n = 1, 1%), and right hepatic duct injury ( n = 1, 1%). Conclusion: Transcystic LCBDE is an effective and safe option for treatment of CBD stones. While a transcystic approach does not guarantee clearance of the CBD, it avoids the morbidity associated with a choledochotomy and can often prevent patients from having to undergo an additional procedure.
A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes
Wilke, Benjamin K. , Garner, Hillary W. , Bestic, Joseph M. , Chase, Lori A. , Heckman, Michael G. , Schoch, Jennifer J. , Attia, Steven , Heckman, Michael G , Wilke, B K , Garner, Hillary W

Mayo Clinic

Clinical Cancer Research | December 1, 2022 | Volume: 29 | Issue: 3 | Pages: 541-547

10.1158/1078-0432.ccr-22-2732 | PMID 36455003 Get It

Abstract Purpose: The purpose of this pilot study was to examine the clinical efficacy and safety of serial triamcinolone injections for the treatment of desmoid tumors. Patients and Methods: Nine patients were enrolled into this prospective study and underwent three serial ultrasound-guided triamcinolone injections (120 mg) at 6-week intervals. MRI was compared at baseline and every 6 months, out to 24 months. Safety and tolerability were assessed by clinical evaluation and questionnaires, including the 12-item short form survey (SF-12), visual analog scale (VAS), and desmoid patient-reported outcome (PRO) tool. Results: At 24 months, 8 (88.9%) patients demonstrated a reduction in the volume of their tumor while 1 (11.1%) enlarged. Median tumor volume change was −26.9% (−81.1% to 34.6%; P = 0.055) All 9 tumors remained stable based on World Health Organization criteria, whereas 2 (22.2%) demonstrated partial response based on RECIST. There was a significant decrease in the tumor:muscle postcontrast mean signal intensity ratio at 6 months (P = 0.008) and 24 months (P = 0.004). There was a similar decrease in the tumor:muscle T2 mean signal intensity ratio at 24 months (P = 0.02). We found no difference in the SF-12 and VAS scores, but there were significant improvements in the desmoid PRO. Conclusions: Treatment of desmoid tumors with serial triamcinolone injections appears safe and well tolerated by patients, with a 22% partial response based on RECIST. Further research is needed to confirm our results and determine factors predictive of response.
Multisource feedback in health professions education
Lui, Justin K. , Duke, Jennifer D. , Russo, Joseph V., Kelm, Diana J. , Hinkle, Laura , Hinkle, Laura

Mayo Clinic

The Clinical Teacher | November 30, 2022 | Volume: 20 | Issue: 1 | Pages: No page available

10.1111/tct.13555 | PMID 36446412 Get It

A Fluke Diagnosis
Ahamed, Summaiyya Hanum, Ho, Jennifer , Ho, Jennifer, Venkatesh, Sudhakar K.

Mayo Clinic

Annals of the Academy of Medicine, Singapore | November 29, 2022 | Volume: 42 | Issue: 7 | Pages: 368-370

10.47102/annals-acadmedsg.v42n7p368 Get It

The Mydrug Platform Trial: Efficacy and Safety of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Patients with Functionally High-Risk Multiple Myeloma
Kumar, Shaji , Biran, Noa , Ye, Jing Christine, Zonder, Jeffrey A. , Syed, Umar , Yesil, Jennifer, Woolley, Karen, Mulligan, George, Hofmeister, Craig C. , Kaur, Gurbakhash , Cho, Hearn Jay

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4434-4435

10.1182/blood-2022-163737 Get It

Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients
Yadav, Saurabh, Furman, Richard R. , Brown, Jennifer R. , Khalsa, Jasneet Kaur , Murali, Ishwarya , Kay, Neil E. , Braggio, Esteban

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12373-12374

10.1182/blood-2022-166648 Get It

Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
Bock, Allison M. , Tawfiq, Reema, Poonsombudlert, Kittika , Maliske, Seth , Kabat, Brian, Gysbers, Brianna, Smith, Katherine E. , Inwards, David J. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Smith, Katherine E R , Gile, Jennifer , Larson, Melissa C. , Maurer, Matthew J. , Cerhan, James R. , Hwang, Steven R. , Paludo, Jonas , Habermann, Thomas M. , Ayyappan, Sabarish Ram , Witzig, Thomas E. , Farooq, Umar , Wang, Yucai

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519

10.1182/blood-2022-165419 Get It

Autologous Hematopoietic Cell Transplant Consolidation for First Response Is Associated with Longer Survival in Patients with Nodal Peripheral T-Cell Lymphoma
Rose, Ashley , Eatrides, Jennifer , Lazaryan, Aleksandr , Ibarz, Javier Pinilla, Liu, Hien , Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, Sokol, Lubomir , Zhang, Yumeng , Saeed, Hayder , Shah, Bijal , Khimani, Farhad , Locke, Frederick L. , Jain, Michael D. , Kim, Jongphil , Zhang, Ling , Nishihori, Taiga , Sokol, Lubomir

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6569-6570

10.1182/blood-2022-168347 Get It

Hypomagnesemia and Prognosis in Newly Diagnosed Diffuse Large B Cell Lymphoma
Smith, Alexandra N., Ruan, Gordon, Abeykoon, Jithma P., McMahon, M. Molly , Gile, Jennifer , Maurer, Matthew J. , Abeykoon, Jithma P. , Witzig, Thomas E.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11919-11920

10.1182/blood-2022-156361 Get It